Precigen reports fourth quarter and full year 2021 financial results

Germantown, md., march 1, 2022 /prnewswire/ -- precigen, inc. (nasdaq: pgen), a biopharmaceutical company specializing in the development of innovative gene and cell therapies to improve the lives of patients, today announced fourth quarter and full year 2021 financial results.
PGEN Ratings Summary
PGEN Quant Ranking